InvestorsHub Logo
Followers 415
Posts 52354
Boards Moderated 13
Alias Born 12/16/2001

Re: None

Thursday, 10/23/2014 3:31:29 PM

Thursday, October 23, 2014 3:31:29 PM

Post# of 69
Novo is studying the injected drug - already on the market as a treatment for type-2 diabetes under the brand name Victoza

- as a therapy for the seriously obese, with pivotal clinical trial results due in the first half of next year 2013.

Do not know how this turned out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVO News